CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Impaired FGF–19 release and hepatic FGF–19 resistance in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD)
DOI 10.1055/s-0031-1295852
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Friedrich, HU Marschall, F Lammert
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: FGF–19, a novel intestinal hormone, is secreted in the terminal ileum postprandially in response to bile salts. NAFLD is common in obesity, but the molecular mechanisms of NAFLD in non-obese patients remain yet to be defined. FGF–19 could possibly play a beneficial role in NAFLD. The aim of our study was to compare FGF–19 serum concentrations and hepatic response to this enterokine in overweight and obese NAFL…
Zitieren
Zitierempfehlung
D Friedrich, HU Marschall, F Lammert (2012) Impaired FGF–19 release and hepatic FGF–19 resistance in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD). Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295852
Mit CareLit weiterarbeiten